Injection device and method for unlocking the operation of an injection device - Patents.com
The injection device addresses the challenge of preventing cross-use of drug containers by using an electronic interlock system with a short-range communication interface, ensuring compatibility and safety, and simplifying integration into existing devices.
Patent Information
- Application Number
- JP2024526555
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-03
- Filing Date
- 2022-11-01
- Publication Date
- 2024-11-13
AI Technical Summary
Existing injection devices face challenges in preventing unintentional cross-use of interchangeable drug containers, requiring complex mechanical redesigns and posing safety risks for patients with chronic diseases, especially those with visual impairments and frailty.
An injection device with a housing and drive mechanism that includes an interlock controlled by an electronic unit, utilizing a short-range communication interface to verify drug container identifiers through an external electronic device, ensuring compatibility and preventing unauthorized use.
Enhances patient safety by preventing mismatched drug container usage, simplifying integration into existing devices, and reducing manufacturing complexity while maintaining ease of use.
Smart Images

Figure 2024542082000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates to an injection device, such as a pen injector, and a method for unlocking the operation of the injection device, for example by using an external electronic device. In a further aspect, the present disclosure relates to an electronic device and an injection or drug delivery system, and a computer readable medium, implementing the unlocking of the injection device. [Background technology]
[0002] Drug delivery devices for setting and dispensing single or multiple doses of liquid medication are per se widely known in the art. Typically, such devices have substantially the same purpose as a common syringe.
[0003] Drug delivery devices such as pen-type injectors must meet several user-specific requirements. For example, in the case of patients with chronic diseases such as diabetes, the patient may be physically frail and may also have impaired vision. Therefore, a suitable drug delivery device specifically intended for home medicines must be robust in construction and should be easy to use. Furthermore, the operation and general handling of the device and its components should be straightforward and easily understandable. Such an injection device should set and subsequently dispense doses of variable sized medications. Furthermore, the dose setting procedure as well as the dose dispensing procedure must be simple to operate and clear.
[0004] Patients with certain diseases may require that a certain amount of medication be injected via a syringe pen or infused via a pump.
[0005] Some drug delivery or injection devices select a variable size dose of drug and inject a pre-set dose, while other injection devices set a fixed dose and dispense it, where the amount of drug to be injected according to a given prescription schedule is always the same and does not or cannot be changed over time.
[0006] Some injection devices are implemented as reusable injection devices, where the user replaces a drug container such as a cartridge, while other injection devices are implemented as disposable injection devices, where the intention is to discard the entire injection device when the contents, i.e. the drug, have been used up.
[0007] In the case of a reusable injection device, the drug container, i.e. cartridge, must be replaced when the drug is exhausted. Here, the drug container, e.g. a glass cartridge filled with drug, must be replaced. Some primary drug containers, e.g. in the form of a drug-filled cartridge, are pre-assembled in a housing component of the injection device, such as a cartridge holder.
[0008] In any case, in the case of a reusable device, it should be ensured that only dedicated drug containers or dedicated housing components pre-assembled with such drug containers can be used with dedicated drive mechanisms of the injection device.
[0009] Typically, a wide variety of primary drug containers may be provided, differing in fill volume or drug substance or concentration. When drug containers are exchanged, it must be ensured that an injection device or drive mechanism can only be used in conjunction with dedicated drug containers intended for use with such a particular type of injection device or drive mechanism. Unintended cross-use of mismatched pairs of drug containers and drive mechanisms or injection devices must be avoided.
[0010] Some approaches have proposed to mechanically code the primary container, e.g. the drug container and / or the cartridge holder with such drug container, in order to prevent unintended mechanical coupling to a mismatched drive mechanism or a mismatched injection device. Such a solution requires redesigning each mechanical component of the injection device. Providing a wide variety of different mechanically coded housing components is very complicated in terms of injection device manufacturing and manufacturing logistics. Summary of the Invention [Problem to be solved by the invention]
[0011] It is therefore intended to provide an improved injection device, electronic device, injection system, method of operating an injection device, and computer readable medium that improves patient safety and prevents unintended cross-use of interchangeable drug containers with the injection device. The solution aims to avoid mechanical redesign of housing components of current injection devices. It is desirable to provide a solution that can be easily incorporated into current injection devices or injection systems. The solution should be easily applicable to different demands or different scenarios of use of the injection device. [Means for solving the problem]
[0012] In one aspect, the present disclosure relates to an injection device for injecting a dose of a medicament. The injection device includes a housing configured to accommodate a medicament container. The injection device further includes a drive mechanism operably engageable with the medicament container to expel or draw a dose of the medicament from the medicament container. The drive mechanism includes at least one interlock configured to disable at least one of dose setting and dose dispensing of the medicament. When the interlock is activated, at least one of dose setting and dose dispensing is disabled. When the interlock is disabled, dose setting and / or dispensing is possible.
[0013] An identifier on or associated with the medication container is further provided. Furthermore, the injection device includes an electronic unit. The electronic unit or electronic module is operable to control the at least one interlock. The injection device further includes a short-range communication interface for communicating with a corresponding short-range communication interface of an external electronic device to obtain information indicative of the identifier or data provided by the identifier. The electronic unit is further configured to process a signal of the short-range communication interface to at least temporarily deactivate the at least one interlock.
[0014] Typically, the electronic unit and / or the short-range communications interface is operable to read information directly from or communicate with the identifier when the identifier is provided on or associated with the medication container.
[0015] Here, the information indicative of the identifier and / or the identifier information indicative of the medicament container can be captured, read and / or processed by the external electronic device. Based on the identifier-related information extractable by the external electronic device, a respective signal can be transmitted from the external electronic device to a short-range communication interface of the electronic unit of the injection device. Based on the signal obtained from the external electronic device and based on a signal of the short-range communication interface derived from the signal obtained from the external electronic device, at least one interlock can be at least temporarily deactivated.
[0016] When the information or data indicative of the identifier matches the associated data of a given medication container, the respective medication container can be used with the drive mechanism of the injection device.
[0017] In some examples, if the identifier does not match the drive mechanism and if information obtained from the identifier by the external electronic device and communicated to the electronic unit via the short-range communication interface does not match the associated data of a given medication container, the interlock remains activated and use of the injection device, for example for setting a dose and / or dispensing, is prevented or blocked.
[0018] The use of the external electronic device as a kind of electronic relay that captures, retrieves, acquires or extracts data from the identifier provides a wide variety of technically possible implementations of the identifier on or associated with the medication container. In this way, the communication capabilities or communication hardware of the electronic unit do not necessarily have to match the technical implementation of the identifier. Instead, the external electronic device can be used as a data transmission device or data converter. Here, the external electronic device must be able to cooperate with both the identifier on or associated with the medication container and the short-range communication interface of the electronic unit of the injection device.
[0019] Thus, the identifier can be implemented as an electronic identifier, an electronic passive identifier, an optical or visual identifier, etc. It is only necessary that the identifier cooperates and matches with a communication interface or a sensor of the external electronic device, and that the external electronic device is able to communicate with the electronic unit of the injection device via the short-range communication interface.
[0020] In typical examples, the external electronic device is implemented as a smartphone, a smartwatch, or a tablet computer. The external electronic device is capable of reading or capturing the identifier. Furthermore, it can communicate, e.g., wirelessly, with a short-range communication interface of the electronic unit of the injection device. Thus, the electronic unit can be embedded in or on the injection device. The electronic unit can be located inside the housing of the injection device and can be permanently coupled or assembled inside the injection device. In some examples, the electronic unit is an embedded electronic unit that is integrated into the injection device or its drive mechanism.
[0021] In such instances, establishing a direct communication link between an identifier provided on or associated with the medication container and the electronic unit and / or its short-range communication interface can be very complicated. Typically, setting up a communication link using a short-range communication interface requires power sources for both the transmitting and receiving devices. Currently proposed solutions for identifiers that provide information that can be extracted, captured, or obtained via an external electronic device no longer require the identifier to be provided with its own source of electrical energy. This allows the identifier to be implemented as a passive component, e.g., a non-energized electrical or electronic component.
[0022] The external electronic device can be implemented in a variety of different ways: In one example, the external electronic device is only capable of reading or capturing the identifier and transmitting the identifier information to the electronic unit via a communication link between a corresponding short-range communication interface of the external electronic device and a short-range communication interface of the electronic unit of the injection device.
[0023] Signal processing can then be performed exclusively by the electronic unit of the injection device, for example to keep the interlock activated when the identifier does not match a predetermined requirement, demand or usage scenario. The electronic unit can keep the at least one interlock activated, so that setting and / or administering a dose is and remains disabled. When data obtained from the identifier matches a predetermined requirement, demand or usage scenario, the electronic unit can at least temporarily deactivate the at least one interlock, and the drive mechanism becomes unlocked to effect setting and / or injecting a dose of the medicament.
[0024] In such an example, where the processing of data is exclusively performed by the processor of the electronic unit of the injection device, the external electronic device does not need to provide any kind of data processing. The external electronic device simply needs to read or obtain the data or information from the identifier and can transfer or transmit the respective information consistently to the electronic unit. In such an approach, only a minimal application of software or hardware to the external electronic device is required.
[0025] In another example, the processing of the information extracted from the identifier can be performed by an external electronic device. The external electronic device can then be operable to compare the data obtained from the identifier with predetermined requirements, demands or usage scenarios of the injection device. To that end, the external electronic device can be equipped with a respective device specific software or computer program, e.g. an app.
[0026] When data obtained from the identifier matches a predetermined need, requirement, or usage scenario, the external electronic device can unlock the at least one interlock via a short-range communication interface that communicates with each other, in such a solution, the external electronic device is pre-authenticated to control the at least one interlock of the electronic unit.
[0027] According to a further example, the housing of the injection device comprises a longitudinal structure. The housing can extend along the longitudinal direction. The housing can comprise a distal housing component and a proximal housing component. The distal housing component, also denoted as a cartridge holder, is configured to house the medicament container. The proximal housing component is configured to house or support the drive mechanism. The distal housing component comprises a distal end facing away from the proximal housing component. The distal end of the distal housing component typically comprises or is coupled to an injection needle to pierce or puncture the biological tissue to inject the medicament.
[0028] The proximal end of the distal housing component is removably connectable to the distal end of the proximal housing component. By removing or disconnecting the distal housing component from the proximal housing component, the drug container, e.g., a drug-filled cartridge, can be replaced as needed.
[0029] Furthermore, the drive mechanism provided on or in the proximal housing component is resettable: when the housing components are uncoupled, the drive mechanism typically undergoes a reset action so that the injection device can be set to an initial configuration after inserting a new drug container into the distal housing component and when the distal housing component is recoupled with the proximal housing component.
[0030] According to a further example, the identifier is located on or inside the distal housing component. The electronic unit is provided in or on the proximal housing component. Typically, the electronic unit and / or its at least one interlock is mechanically engaged with at least one movable component of the drive mechanism. The electronic unit can be provided inside the proximal housing component. The electronic unit can be provided or located at or near the proximal end of the proximal housing component. If the identifier is located on or inside the distal housing component, the identifier may be located very far from the electronic unit and / or far from the short-range communication interface of the electronic unit.
[0031] In some examples, the identifier is located on the medicament container. In other examples, the identifier is located on the distal housing component, which is pre-assembled with the medicament container, where the medicament container can be permanently coupled to the distal housing component. Typically, the distal housing component is removably coupleable and / or removably securable to the proximal housing component.
[0032] According to a further example, the identifier comprises at least one of an optical code and a visual code. The optical code or the visual code can be captured by an external electronic device, where the external electronic device comprises at least one light sensor. The external electronic device can comprise a two-dimensional sensor array. The external electronic device can comprise an imaging sensor to capture a two-dimensional or one-dimensional image of the optical code. Typically, the external electronic device comprises a camera to capture an image of the optical code or the visual code.
[0033] The external electronic device may be further configured to extract code information or medication-related information from the captured optical or visual code and provide or transmit the extracted data or information to the electronic unit via a communication link between the short-range communication interface of the electronic unit and a corresponding short-range communication interface of the external electronic device.
[0034] Using the external electronic device, it is generally possible to assemble the distal and proximal housing components with the drug container located inside the housing of the injection device, and then perform a validation or approval routine of the drug container via the identifier, the external electronic device, and short-range communication between the external electronic device and the electronic unit to at least temporarily deactivate the interlock of the injection device.
[0035] In a further example, the identifier comprises a passive electronic identifier. The passive electronic identifier is capable of electronically communicating with an external electronic device. It may not be compatible with a short-range communication interface of the electronic unit of the injection device. Such incompatibility may be overcome or avoided by the external electronic device being operable to read the identifier and to communicate with the short-range communication interface of the electronic unit of the injection device.
[0036] According to a further example, a passive electronic identifier is a non-energized electronic identifier that lacks a persistent source of electrical energy, which allows for reduced manufacturing costs and storage space for implementing the identifier on the medication container or distal housing component. A passive or non-energized electronic identifier can be manufactured in large quantities at low or affordable cost. It can be implemented or configured as a disposable electronic identifier.
[0037] According to further examples, the passive electronic identifier includes a microchip and an antenna. The antenna is configured to harvest electrical energy from a surrounding electromagnetic field. In some examples, the passive electronic identifier is implemented as a near field communication (NFC) tag. In some examples, the passive electronic identifier includes a passive RFID tag. Furthermore, in some examples, the passive electronic identifier includes a near field communication tag configured to communicate with a corresponding near field communication interface of an external electronic device. Here, the external electronic device includes two communication interfaces, namely a near field communication interface that communicates with the passive electronic identifier provided on or associated with the medication container. The external electronic device further includes the above-mentioned short field communication interface that communicates with a short field communication interface of the electronic unit of the injection device.
[0038] The identifier, when implemented as a near field communication tag, e.g. an NFC tag or an RFID tag, is inherently not operable to communicate with a short-range communication interface of the electronic unit of the injection device, which may not have a suitable near field communication interface to read or capture data from the near field communication tag of the identifier.
[0039] In some examples, the external electronic device is compatible with both a near-range communication interface and a short-range communication interface and provides a relay function to capture or obtain information from the electronic identifier and transmit the respective information to the electronic unit via the short-range communication interface.
[0040] The communication link between the external electronic device and the passive electronic identifier may be of the bidirectional type, so that the external electronic device may not only be operable to read or retrieve information from the passive electronic identifier, but also to transmit and / or store data in the passive electronic identifier or to modify the non-volatile memory of the passive electronic identifier.
[0041] In this way, when the passive electronic identifier is read by the near field communication interface of the external electronic device, the passive electronic identifier of the injection device can be deactivated, where it can be electronically marked as being in use or the associated medication container has been used and can no longer be used, for example with other injection devices.
[0042] According to a further example, the electronic identifier includes non-volatile memory that stores at least one of the following: a medication name, a medication manufacture date, a medication expiration date, a medication lot number, or a unique medication container ID. In this manner, a wide variety of medication-related data can be stored in or by the identifier and captured or extracted through reading of the identifier by an external electronic device.
[0043] The above mentioned medication related parameters such as medication name, manufacturing date, expiration date, lot number, or unique medication container ID may also be coded into an optical or visual code to be captured by a camera of the external electronic device. In some examples, the visual code may include a QR code or a data matrix code, which may be converted into respective data via a network connection using respective decoders.
[0044] According to a further example, the non-volatile memory of the electronic identifier is at least one of erasable and writable by the NFC interface of the external electronic device. In this way, the non-volatile memory of the passive electronic identifier can be reconfigured. The non-volatile memory can be provided with a verification flag indicating whether the respective electronic identifier has previously undergone a read or write operation. By providing an erasable or writable non-volatile memory, such a read or invalidation flag can be set or reconfigured when the non-volatile memory is first read or read by the near field communication interface of the external electronic device.
[0045] In this manner, patient safety may be enhanced, for example, by preventing multiple consecutive uses of the same medication container with the same or different injection devices. In particular, medication containers with unique medication container IDs may be marked as deactivated, such that misuse of the container, e.g., unintended substitution of a container, is somewhat more difficult to achieve, since such unauthorized containers would then be inoperable to deactivate the interlock of the injection device.
[0046] In a further example, the short-range communication interface of the electronic unit comprises a wireless communication interface based on one of the following communication standards: Bluetooth, Bluetooth low energy (BLE), Zigbee or Wi-Fi. Typically, the short-range communication interface of the electronic unit and the corresponding short-range communication interface of the external electronic device comprise a transmission range that is greater than the transmission range of the short-range communication between an NFC tag of the identifier and the communication interface of the external electronic device.
[0047] In some examples, the spatial distance between the identifier provided on the drug container or on the distal housing component and the electronic unit of the injection device is larger than the transmission range of the short-range communication interface. Therefore, providing the electronic unit of the injection device with a short-range communication interface would be of little use, since the drug container with the respective passive electronic identifier assembled inside the housing would be outside the transmission range of the short-range communication interface. Here, the external electronic device, typically implemented as a portable electronic device, provides a relay function to enable indirect communication between the electronic identifier provided on or associated with the drug container and the electronic unit provided, for example, at the proximal end of the housing of the injection device.
[0048] According to a further example, the at least one interlock of the drive mechanism includes an electromechanical interlock configured to mechanically engage a first component of the injection device and a second component of the injection device. The first component is movable relative to the second component for at least one of dose setting and dose injection of the medicament. Typically, for at least one of dose setting and dose dispensing or dose injection, the at least one interlock is operable to switch between an interlock state in which the first component is movably locked to the second component and a released state in which the first component is movable relative to the second component.
[0049] In some examples, the first component is longitudinally movable relative to the second component for at least one of dose setting and dose injection. In other examples, the first component is rotatable relative to the second component for at least one of dose setting and dose injection. In the case of rotatable relative displacement between the first and second components, the axis of rotation typically extends along the longitudinal or axial direction of the housing of the injection device.
[0050] In some examples, the first component undergoes a helical movement relative to the second component for dose setting and / or dose injection of the medicament. At least one of the first and second components may belong to the drive mechanism. In some examples, both the first and second components belong to the drive mechanism of the injection device. In other examples, at least one of the first and second components is part of or forms the housing of the injection device.
[0051] Typically, in further examples, the electromechanical interlock includes an electrically implemented actuator operably engaged with the latch. In some examples, the latch is movable by the actuator along a longitudinal direction, along a radial direction, and / or along a tangential direction relative to the cylindrical or tubular geometry of the housing of the injection device. Typically, the actuator is located and / or fixed to one of the first and second components. The latch can be provided on the same component and can be mechanically engagable with the other of the first and second components to block or prevent relative movement between the first and second components when the interlock is in an interlocked state.
[0052] In some examples, the drive mechanism of the injection device includes a piston rod, a number sleeve, a drive sleeve, or a driver, and at least one of a dose dial and a trigger or a dose button. Typically, the dose dial is rotatable relative to the housing for dose setting. During dose setting, the rotational movement of the dial is transferred to a respective rotational movement of the number sleeve. Here, at least one of the dose dial and the number sleeve can be locked non-rotatably and / or non-translatably by an interlock to prevent dose setting.
[0053] For dose dispensing or dose injection, the trigger or dose button must be depressed by the user. The trigger button can be depressible relative to the dose dial, the housing, the number sleeve, or the piston rod. During dose dispensing, the driver or drive sleeve typically undergoes a rotational motion, which is transferred to a longitudinal and / or rotational motion of the piston rod. During dose injection, the number sleeve typically rotates in a direction opposite to the direction of rotation during dose setting. Here, the interlock can be operable to block the actuation or movement of the trigger, block the rotation of the driver or drive sleeve, block the rotation or movement of the piston rod, and / or block or inhibit the rotation or movement of the number sleeve.
[0054] In addition to these examples, further implementations of the interlock or electromechanical interlock are possible and contemplated, so long as the first and second components that are to lock and engage with each other undergo relative movement during at least one of dose setting and dose dispensing.
[0055] According to a further example, the drive mechanism includes at least one clutch operable to switch the drive mechanism between a dose setting mode and a dose injection or dose dispensing mode, and the at least one interlock is operably engaged with the at least one clutch to selectively disable switching of the drive mechanism from one of the dose setting mode and the dose injection mode to the other of the dose setting mode and the dose injection mode.
[0056] In some examples, the drive mechanism includes a first clutch and a second clutch. The first clutch allows the number sleeve to selectively engage with the dose dial, the driver, or the drive sleeve of the drive mechanism. In this way, the rotation of the dose dial can be transferred to the respective rotation of the number sleeve during dose setting. During dose injection, the number sleeve can be decoupled and released from the dose dial. Here, the number sleeve can be rotated in the opposite rotational direction, but the dose dial does not have to follow its rotation and remains non-rotatably locked to the housing of the injection device.
[0057] The second clutch allows the dose dial and / or number sleeve to selectively engage with a driver or drive sleeve of the drive mechanism. Further, the second clutch and / or third clutch can provide selective engagement between the driver or drive sleeve and the piston rod to move the piston rod distally exclusively during dose injection.
[0058] Generally, the drive mechanism of the injection device can be implemented in a variety of different ways. One example of a drive mechanism is disclosed, for example, in WO2004 / 078239A1, the entirety of which is incorporated herein by reference. Another example of a drive mechanism implemented with an injection device is disclosed, for example, in WO2014 / 033195A1, the entirety of which is incorporated herein by reference.
[0059] According to a further example, the at least one interlock is controlled by a processor of the electronic unit, the processor being configured to activate the at least one interlock when one or several of the following conditions are detected by the electronic unit: end of dose injection, exhaustion of the contents of the drug container, lapse of a predefined time with the at least one interlock in a deactivated state, removal or insertion of the drug container from the housing, execution of a manual reset of the drive mechanism, or deactivation of the communication link between the short-range communication interface and the external electronic device.
[0060] Any further circumstances may be provided that trigger the processor to activate or deactivate the interlock. Typically, any of the above circumstances may result in automatic activation of the interlock, which effectively prevents unintended or unauthorized use of the injection device. Any of the above mentioned circumstances may be detected, for example, by at least one sensor, as further described below.
[0061] According to a further example, the injection device includes a drug container filled with a drug. The drug container is disposed inside the housing. Typically, the drug container includes a cartridge filled with a drug. The cartridge may include a tubular shaped barrel, e.g. made from a glass material. The barrel may be sealed proximally by a moveable stopper along the length of the barrel to expel the liquid drug through a distally located barrel outlet.
[0062] The distally located outlet can be sealed by a seal. The seal at the distal end of the cartridge can include a sealing disk, for example made from a rubber material and pierceable by a double-ended injection needle. The rubber seal can be fixed or assembled to the distal end of the tubular barrel by a crimped metal cap.
[0063] According to a further example, the medicament container can be non-removably attached to the distal housing component. The distal housing component typically includes a tubular shaped cartridge holder shaped and configured to accommodate the medicament cartridge therein. The cartridge holder can include snap features to secure the cartridge inside the cartridge holder. In this way, a pre-assembly of the cartridge holder and the cartridge can be provided that can be distributed as a product to the end consumer or patient. In such a pre-assembly, the identifier can be provided on the outer surface of the distal housing component and thus on the outer surface of the cartridge holder.
[0064] In another example, the identifier is provided on an exterior surface of the barrel of the drug container.In another example, the identifier is provided on or inside the stopper of the cartridge.
[0065] If the identifier is located on or in the drug container, it can be readable by an external electronic device even when the cartridge or drug container is located inside or assembled to the distal housing component. To this end, a window or aperture may be provided in the sidewall of the distal housing component. Alternatively or additionally, the sidewall of the distal housing component is transparent or translucent.
[0066] In other implementations, for example, when the identifier is implemented as a passive electronic identifier, the sidewall of the distal housing component may be transparent to electromagnetic radiation, allowing the passive electronic identifier to be read by electromagnetic radiation.
[0067] According to a further example, the electronic unit of the injection device includes at least one sensor that detects or measures the movement of at least one movable component of the injection device. The movable component of the injection device may indicate a particular device configuration or device operation. By detecting the movement or the magnitude of the movement of the movable component, the electronic unit is provided with information regarding the operational status of the injection device.
[0068] Typically, in some instances, the sensor is operable to quantitatively measure the extent of movement of the at least one movable component. The at least one sensor may be operable to measure the extent of rotation and / or the extent of longitudinal movement of the at least one movable component, for example relative to the housing of the injection device or relative to another movable component of a drive mechanism of the injection device.
[0069] Data regarding the dose size can be derived by at least one sensor, which is operable to provide an electrical signal indicative of the size of the dose actually set and / or dispensed or injected by the drive mechanism of the injection device. Typically, the electronic unit comprises a memory and a clock. In this way, the dose history or injection history can be automatically captured and stored in the memory of the electronic unit.
[0070] By means of the short-range communication interface and by means of the communication link with the external electronic device, the medication-related data, such as the injection history, and therefore the injection-related data, can be synchronized with the external electronic device and transmitted to a healthcare provider for further data analysis. In this way, the repeated use of the injection device can be precisely tracked and measured, and the user's compliance with a given prescription schedule can be monitored.
[0071] According to a further aspect, the present disclosure relates to a kit of injection devices, in particular a first type of injection device and at least a further type, e.g., a second type of injection device. The first type and the second type of injection device are differentiated by their drug or drug container. The first type of drug container can be differentiated from the second type of drug container by its size, type of drug, pharmacologic active substance, and / or concentration of pharmacologic active substance.
[0072] The first type of medicament container is configured exclusively for use with a first type of drive mechanism. The second type of medicament container is configured exclusively for use with a second type of drive mechanism. Unintended cross-use, i.e., use of a first type of medicament container with a second type of injection mechanism, should be avoided.
[0073] To that end, a first type of drug container comprises and / or is associated with a first type of identifier; a second type of drug container comprises and / or is associated with a second type of identifier. By means of the identifiers the respective type of drug container can be detected, where the identifiers provide a certain coding; the first type of identifier represents a first coding; and the second type of identifier represents a second coding. The different types of identifiers are processable and / or detectable by the electronic unit to activate or deactivate the interlock.
[0074] The identifier may represent an electronic coding or an electronically detectable coding. Such an identifier or coding allows the use of housing components that are not mechanically coded for the first and second types of injection devices. Even if a distal housing component with a first type of drug container is assembled with a proximal housing component of a second type and comprises a second type of injection device, such combination is not operable to disable or deactivate the interlock of the drive mechanism. Setting and / or injection of a dose is effectively prevented.
[0075] In some examples, the electronic unit of the injection device is typically not operable to collect or read information of the identifier. The short-range communication interface of the electronic unit may not be operable to communicate with the identifier or to read the identifier. The identifier may cooperate and / or match with a communication interface or a sensor of an external electronic device, and the external electronic device may communicate with the electronic unit of the injection device via the short-range communication interface.
[0076] In this way, the communication capabilities or communication hardware of the electronic unit do not necessarily have to match the technical implementation of the identifier. Instead, an external electronic device can be used as a data transmission device or data converter, where the external electronic device is enabled to cooperate with both the identifier provided on or associated with the medication container and the short-range communication interface of the electronic unit of the injection device.
[0077] According to a further aspect, the present disclosure also relates to an electronic device, the electronic device including a short-range communication interface operable to communicate with the short-range communication interface of the injection device described above, the electronic device further including a wireless reader interface, the wireless reader interface directly or indirectly coupled to the short-range communication interface and operable to capture or read an identifier provided on or associated with a medication container of the injection device.
[0078] The electronic device can be implemented as a mobile or wearable electronic device. The electronic device can include a smartphone, a smartwatch, or a tablet computer. The electronic device can provide a relay operable to read or capture information of an identifier provided on or associated with the medication container and transmit or send the information to a short-range communication interface of the electronic unit of the injection device. The electronic device can consistently transfer or transmit the information collected from the identifier to the electronic unit of the injection device.
[0079] Here, the electronic unit of the injection device is typically not operable to collect or read information of the identifier. In some examples, the identifier of the drug container is exclusively readable by a short-range communication interface having a limited transmission range, which is smaller than the spatial distance between the electronic unit of the injection device and the identifier when the identifier is provided on one of the drug container and the distal housing component and when the drug container assembled inside the distal housing component is disposed inside the housing of the injection device.
[0080] In some examples, the identifier of the medication container may be readable exclusively by a wireless reader interface of the electronic device.
[0081] In general, the electronic device is configured to communicate and / or cooperate with the injection device described above, in which case all of the configurations, advantages and benefits described above with respect to the injection device apply equally to the electronic device.
[0082] According to a further example, the electronic device, and in particular its wireless reader interface, includes at least one of a camera for capturing the optical code of the identifier and a short-range communication interface for communicating with a passive electronic identifier, e.g. an NFC tag of the identifier. In any case, the wireless reader interface of the external electronic device is operable to acquire, capture, read or extract information of the identifier and to send that information to the electronic unit of the injection device via a short-range communication link between the short-range communication interface of the electronic unit of the injection device and a corresponding short-range communication interface of the electronic device.
[0083] According to a further example, the electronic device includes a long-range communication interface configured to communicate with the database over a network. The long-range communication interface can be implemented as a cellular-based communication interface, such as USM, LTE, 4G, 5G, 6G, or any other electronic communication standard. The long-range communication interface can be implemented to communicate in a wireless wide area network (WANW). Such networks are typically created through the use of cellular signals provided and maintained by a particular cellular service provider.
[0084] The short-range communication interface can be implemented as a wireless local area network (WLAN). Such a network is a wireless network that uses radio waves. Backbone networks typically use cables with one or more wireless access points that connect wireless users to a wired network. The transmission range of such a WLAN network can generally be from a single room to an entire campus. The short-range communication interface can also be implemented to communicate with a wireless personal area network (WPAN), which is typically implemented as a short-range network using Bluetooth or Bluetooth low energy (BLE). The short-range communication interface can provide a transmission range of a few meters.
[0085] The above-described short-range communication interface uses a communication protocol for communication between two electronic devices at a distance of just a few centimeters or less, respectively. Typically, the transmission range of the short-range communication interface is 4 cm or less, 3 cm or less, 2 cm or less. The short-range communication interface may be based on inductive coupling between two so-called antennas present on the NFC-enabled device communicating in one or both directions, using a data rate of 106 to 424 kbit / s, a frequency of 13.56 MHz in the license-free radio frequency ISM band available worldwide using the ISO / IEC 18000-3 air interface standard.
[0086] In the case of electronic devices including a long-range and / or short-range communication interface, the electronic device and / or the electronic unit of the injection device are configured to connect to a database via a network, typically implemented as the Internet. In this way, communication with the database is made possible. Here, data synchronization can be provided. Data from the storage and / or data provided by the database can be compared and evaluated with data obtained from the identifier.
[0087] Here, the electronic device and / or electronic unit can be implemented to transmit identifier-related data to the database and to extract the respective data from the database in return. In this way, information about the identifier and therefore about the medicine container can be synchronized with the data provided to the database. Here, data evaluation or data approval can be performed. For example, by communication between the external electronic device and the database, a check can be performed, for example, whether the unique identifier associated with the medicine container is a valid identifier or whether such identifier is marked as invalid in the database.
[0088] In this way, each individual drug container can be tracked and at least substantially marked in the database as correct or incorrect. Here, a correct identifier stored in the external database can be marked or overwritten as incorrect when the identifier is detected by the external electronic device through data communication over a network between the external electronic device and the database. In this way, unauthorized containers can be precisely detected and thus patient safety can be improved. In effect, only original or genuine drug containers with a correct identifier can be used to unlock the drive mechanism of the injection device.
[0089] According to a further aspect, the present disclosure also relates to an injection system. The injection system includes an injection device as described above, typically comprising a drug container. The injection system further includes an electronic device as described above. In that case, any configurations, effects, and benefits described above with respect to the injection device and / or with respect to the electronic device also apply to the injection system; vice versa.
[0090] According to one example, the distance between the identifier provided on or in one of the distal housing component and the medication container and the short-range communication interface of the injection device is greater than the transmission range of the near-field communication interface of the electronic device. This may be particularly true for examples or implementations of the identifier as a passive electronic identifier, in particular when the identifier is implemented as an NFC tag, where the electronic unit of the injection device may not have a corresponding near-field communication interface or an NFC reader.
[0091] In addition, even if the electronic unit were equipped with such an NFC reader, the spatial distance between such a reader in the electronic unit and the corresponding electronic identifier on the medication container may exceed the transmission range of the NFC communication link, and therefore providing an NFC reader in the electronic unit would be useless or meaningless if the identifier is provided in or on the medication container or in or on the distal housing component, as it would be outside the transmission range of an NFC reader provided, for example, at or near the proximal end of the proximal housing component.
[0092] Here, the external electronic device provides a relay function that communicates with the passive electronic identifier of the medication container and the short-range communication interface of the electronic unit of the injection device.
[0093] According to another aspect, the present disclosure relates to a method of unlocking operation of an injection device for at least one of setting or injecting a dose of a medicament. The injection device includes a housing configured to accommodate a medicament container and a drive mechanism. The drive mechanism is operably engageable with the medicament container to expel or withdraw a dose of the medicament from the medicament container. Typically, the drive mechanism includes a piston rod that exerts distal pressure on a stopper movably disposed in a barrel of the medicament container.
[0094] The drive mechanism further includes at least one interlock configured to disable at least one of the dose setting and the dose dispensing. The method of unlocking the operation of the injection device includes capturing or reading an identifier by a wireless reader interface of an external electronic device. The identifier is provided on or associated with the drug container. In some examples, the identifier is provided on or incorporated into the drug container. In other examples, the drug container can be pre-assembled to a distal housing component of the injection device. Here, the identifier can be attached to or incorporated into the distal housing component.
[0095] The method further includes establishing a communication link between a short-range communication interface of the injection device and a corresponding short-range communication interface of the electronic device, and further includes transmitting information indicative of the identifier and / or information about the identifier or about the medication container from the electronic device to the injection device to at least one of temporarily deactivate and / or reactivate the at least one interlock.
[0096] Additionally or optionally, the method also includes at least temporarily deactivating at least one interlock to assist and / or enable setting and / or dispensing of a dose of the drug.
[0097] In general, the method of unlocking the operation of the injection device will be implemented by combining the injection device described above with the external electronic device described above, and thus by the injection system described above, in which case all the configurations, effects and benefits described above with respect to the injection device, the electronic device and the injection system equally apply to the method of unlocking the operation of the injection device; and vice versa.
[0098] According to a further example, the method includes verifying the identifier by comparing medication-related data obtained from the identifier with predetermined data related to the injection device. In this way, it can be determined or determined whether the identifier matches the predetermined data related to the injection device and whether the medication container is usable or intended to be used with the injection device.
[0099] If the acquired or captured identifier-related data does not match the predetermined data related to the injection device, the drive mechanism is or remains actively locked by the interlock. The injection device is then effectively inoperable to set a dose of medication and / or inject a dose of medication. In a further example, the method and step of validating the identifier can include modifying the identifier. This can be utilized, inter alia, through a short-range communications link between the electronic identifier and the external electronic device.
[0100] Here, in some examples, the external electronic device can read the electronic storage of the passive electronic identifier. Upon such a read operation, a read flag for each of the electronic identifiers can be set to mark the electronic identifier as currently in use or used. At that time, repeated use of the passive electronic identifier and / or the medication container associated with the identifier can be effectively prevented or blocked, for example, to prevent or hinder unintended and / or unauthorized use of the medication container. In that case, the capture or reading of the identifier can include an evaluation or acknowledgement of the status of the read flag provided by the electronic storage of the electronic identifier.
[0101] Alternatively, in a further example, a database request may be invoked using an external database, for example via a network connection, when an identifier provided on or associated with a medication container is read by the external electronic device. In the database, a medication container currently in use may be marked as ready for use or not suitable for use. With such a database request, the external electronic device may gather additional information whether a particular medication container can be used or whether it should not or cannot be used with the injection device.
[0102] Thus, a communication link between an external electronic device and the local electronic unit of the injection device can be used to control, i.e., lock or release, the interlock to enable or disable operation of the injection device with a given drug container.
[0103] According to a further aspect, the present disclosure relates to a computer-readable medium including instructions which, when executed by an electronic device as described above, cause the electronic device to capture or read an identifier provided on or associated with a medication container and establish a communication link between a short-range communication interface of the injection device and a corresponding short-range communication interface of the electronic device. Additionally, the computer-readable medium causes the electronic device to transmit information indicative of the identifier from the electronic device to the injection device to at least temporarily deactivate at least one interlock.
[0104] The computer readable medium is in particular configured to perform the steps of the method for unlocking the operation of the injection device mentioned above, in which case all the features, effects and advantages discussed above with respect to the unlocking method also apply to the computer readable medium mutatis mutandis.
[0105] According to a further aspect, the present disclosure relates to a computer-readable medium comprising instructions, which when executed by a processor of an electronic unit of an injection device, cause the processor to control an interlock of a drive mechanism of the injection device. The computer-readable medium may comprise instructions, which when executed by the processor of the electronic unit, cause the electronic unit to process data obtained from an external electronic device and to lock or unlock at least one interlock based on data or signals obtained from the external electronic device. The computer-readable medium is in particular executable by the electronic unit of the injection device. In that case, all configurations, effects and benefits described above with respect to the injection device equally apply to the respective computer-readable medium; and vice versa.
[0106] Generally, the scope of the present disclosure is defined by the content of the claims. The injection device is not limited to a particular embodiment or example, but includes any combination of elements of different embodiments or examples. In that case, the present disclosure encompasses any combination of claims and any technically feasible combination of the disclosed features with respect to the different examples or embodiments.
[0107] In the present context, the term "distal" or "distal end" refers to the end of the injection device that faces towards the injection site of a person or animal, and the term "proximal" or "proximal end" refers to the opposite end of the injection device that is furthest from the injection site of a person or animal.
[0108] The terms "drug" or "medicament" are used interchangeably herein to describe a pharmaceutical formulation containing one or more active pharmaceutical ingredients or their pharma- ceutically acceptable salts or solvates, and optionally a pharma- ceutically acceptable carrier. An active pharmaceutical ingredient ("API"), in its broadest sense, is a chemical structure that has a biological effect on humans or animals. In pharmacology, drugs or medicines are used to treat, cure, prevent, or diagnose diseases or otherwise improve physical or mental well-being. Drugs or medicines can be used for a limited duration or periodically for chronic disorders.
[0109] As described below, a drug or agent may include at least one API or a combination thereof in various types of formulations for the treatment of one or more diseases. Examples of APIs may include small molecules with molecular weights of 500 Da or less, polypeptides, peptides, and proteins (e.g., hormones, growth factors, antibodies, antibody fragments, and enzymes), carbohydrates and polysaccharides, as well as nucleic acids, double-stranded or single-stranded DNA (including naked and cDNA), RNA, antisense nucleic acids such as antisense DNA and RNA, small interfering RNA (siRNA), ribozymes, genes, and oligonucleotides. Nucleic acids may be incorporated into molecular delivery systems such as vectors, plasmids, or liposomes. Mixtures of one or more drugs are also contemplated.
[0110] The drug or agent can be contained in a primary package or "drug container" adapted for use in a drug delivery device. The drug container can be, for example, a cartridge, syringe, reservoir, or other rigid or flexible vessel configured to provide a chamber suitable for storage (e.g., short-term or long-term storage) of one or more drugs. For example, in some cases, the chamber can be designed to store the drug for at least one day (e.g., from one day to at least 30 days). In some cases, the chamber can be designed to store the drug for about one month to about two years. Storage can be at room temperature (e.g., about 20° C.) or at refrigerated temperatures (e.g., from about −4° C. to about 4° C.). In some cases, the drug container can be or include a dual-chamber cartridge configured to separately store two or more components of a pharmaceutical formulation to be administered (e.g., an API and a diluent, or two different drugs), one in each chamber. In such cases, the two chambers of the dual-chamber cartridge can be configured to allow mixing between two or more components prior to and / or during administration to the human or animal body. For example, the two chambers can be configured to be in fluid communication with each other (e.g., via a conduit between the two chambers) and to allow mixing of the two components by a user, if desired, prior to administration. Alternatively or additionally, the two chambers can be configured to allow mixing upon administration of the components to the human or animal body.
[0111] The drugs or agents contained in the drug delivery devices described herein can be used for the treatment and / or prevention of many different types of medical disorders. Examples of disorders include, for example, diabetes or complications associated with diabetes, such as diabetic retinopathy, thromboembolic disorders, such as deep vein thromboembolism or pulmonary thromboembolism. Further examples of disorders are acute coronary syndromes (ACS), angina, myocardial infarction, cancer, macular degeneration, inflammation, hay fever, atherosclerosis and / or rheumatoid arthritis. Examples of APIs and drugs are those found in handbooks such as Rote Liste 2014 (e.g., but not limited to, main groups 12 (antidiabetic agents) or 86 (oncology agents)) and the Merck Index, 15th edition.
[0112] Examples of APIs for the treatment and / or prevention of type 1 or type 2 diabetes or complications associated with type 1 or type 2 diabetes include insulin, e.g., human insulin, or a human insulin analog or derivative, glucagon-like peptide (GLP-1), a GLP-1 analog or GLP-1 receptor agonist, analog or derivative thereof, a dipeptidyl peptidase-4 (DPP4) inhibitor, or a pharma-ceutically acceptable salt or solvate thereof, or any mixture thereof. As used herein, the terms "analog" and "derivative" refer to a polypeptide having a molecular structure that is formally derivable from the structure of a naturally occurring peptide, e.g., the structure of human insulin, by deletion and / or replacement of at least one amino acid residue present in the naturally occurring peptide and / or by addition of at least one amino acid residue. The added and / or replaced amino acid residue can be either a codable amino acid residue or another naturally occurring residue or a purely synthetic amino acid residue. Insulin analogs are also referred to as "insulin receptor ligands". In particular, the term "derivative" refers to a polypeptide having a molecular structure formally derivable from the structure of a naturally occurring peptide, e.g., the molecular structure of human insulin in which one or more organic substituents (e.g., fatty acids) are attached to one or more of the amino acids. Optionally, one or more amino acids present in the naturally occurring peptide are deleted and / or replaced by other amino acids, including non-codeable amino acids, or amino acids, including non-codeable ones, are added to the naturally occurring peptide.
[0113] Examples of insulin analogues are Gly(A21), Arg(B31), Arg(B32) human insulin (insulin glargine); Lys(B3), Glu(B29) human insulin (insulin glulisine); Lys(B28), Pro(B29) human insulin (insulin lispro); Asp(B28) human insulin (insulin aspart); human insulin in which the proline in position B28 may be replaced by Asp, Lys, Leu, Val or Ala and in which the Lys in position B29 may be replaced by Pro; Ala(B26) human insulin; Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) human insulin.
[0114] Examples of insulin derivatives are e.g. B29-N-myristoyl-des(B30) human insulin, Lys(B29)(N-tetradecanoyl)-des(B30) human insulin (insulin detemir, Levemir®); B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl human insulin; B29-N-palmitoyl human insulin; B28-N-myristoyl-LysB28ProB29 human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin; B30-N-myristoyl-ThrB29LysB30 human insulin. ; B30-N-palmitoyl-ThrB29LysB30 human insulin; B29-N-(N-palmitoyl-gamma-glutamyl)-des(B30) human insulin, B29-N-omega-carboxypentadecanoyl-gamma-L-glutamyl-des(B30) human insulin (insulin degludec, Tresiba®); B29-N-(N-lithocholyl-gamma-glutamyl)-des(B30) human insulin; B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin and B29-N-(ω-carboxyheptadecanoyl) human insulin.
[0115] Examples of GLP-1, GLP-1 analogs and GLP-1 receptor agonists are, for example, lixisenatide (Lyxumia®), exenatide (exendin-4, Byetta®, Bydureon®, a 39 amino acid peptide produced by the salivary glands of the flathead monster), liraglutide (Victoza®), semaglutide, taspoglutide, albiglutide (Syncria®), dulaglutide (Trulicity®), rExendin-4, CJC-1134-PC, PB-1023, TTP-054, langrenatide / HM-11260C (efpegrenatide). , HM-15211, CM-3, GLP-1 Erigen, ORMD-0901, NN-9423, NN-9709, NN-9924, NN-9926, NN-9927, Nodexene, Viador-GLP-1, CVX-096, ZYOG-1, ZYD-1, GSK-2374697, DA-3091, MAR-701, MAR709, ZP-2929, ZP-3022, ZP -DI-70, TT-401 (Pegapamodtide), BHM-034, MOD-6030, CAM-2036, DA-15864, ARI-2651, ARI-2255, Tirzepatide (LY3298176), Bamadutide (SAR425899), Exenatide-XTEN and Glucagon-Xten.
[0116] Examples of oligonucleotides are, for example, the cholesterol-lowering antisense therapeutic mipomersen sodium (Kynamro®) for the treatment of familial hypercholesterolemia, or RG012 for the treatment of Alport Syndrome.
[0117] Examples of DPP4 inhibitors are linagliptin, vidagliptin, sitagliptin, denagliptin, saxagliptin, berberine.
[0118] Examples of hormones include pituitary or hypothalamic hormones or regulatory active peptides and their antagonists, such as gonadotropins (follitropin, lutropin, chorion gonadotropin, menotropin), somatropine (somatropin), desmopressin, terlipressin, gonadorelin, triptorelin, leuprorelin, buserelin, nafarelin, and goserelin.
[0119] Examples of polysaccharides include glycosaminoglycans, hyaluronic acid, heparin, low molecular weight heparin or very low molecular weight heparin or derivatives thereof, or sulfated polysaccharides, such as the above-mentioned polysaccharides in polysulfated form, and / or their pharma- ceutically acceptable salts. An example of a pharma-ceutically acceptable salt of polysulfated low molecular weight heparin is enoxaparin sodium. An example of a hyaluronic acid derivative is Hylan G-F20 (Synvisc®), sodium hyaluronate.
[0120] The term "antibody" as used herein refers to an immunoglobulin molecule or an antigen-binding portion thereof. Examples of antigen-binding portions of an immunoglobulin molecule include F(ab) and F(ab')2 fragments that retain the ability to bind to an antigen. An antibody can be a polyclonal antibody, a monoclonal antibody, a recombinant antibody, a chimeric antibody, a deimmunized or humanized antibody, a fully human antibody, a non-human (e.g., murine) antibody, or a single chain antibody. In some embodiments, an antibody has effector function and is capable of fixing complement. In some embodiments, an antibody has reduced or no binding ability to Fc receptors. For example, an antibody can be an isotype or subtype, an antibody fragment, or a mutant that does not support binding to Fc receptors, e.g., with a mutation or deletion of the Fc receptor binding region. The term antibody also includes antigen-binding molecules based on tetravalent bispecific tandem immunoglobulins (TBTIs) and / or dual variable region antibody-like binding proteins (CODVs) with crossover binding region orientation.
[0121] The term "fragment" or "antibody fragment" refers to a polypeptide (e.g., antibody heavy and / or light chain polypeptide) derived from an antibody polypeptide molecule that does not include the full-length antibody polypeptide but comprises at least a portion of the full-length antibody polypeptide that is still capable of binding to an antigen. An antibody fragment can include truncated portions of a full-length antibody polypeptide, but the term is not limited to such truncated fragments. Antibody fragments useful in the present invention include, for example, Fab fragments, F(ab')2 fragments, scFv (single-chain Fv) fragments, linear antibodies, monospecific or multispecific antibody fragments, such as bispecific, trispecific, tetraspecific and multispecific antibodies (e.g., diabodies, triabodies, tetrabodies), monovalent or multivalent antibody fragments, such as bivalent, trivalent, tetravalent and multivalent antibodies, minibodies, chelating recombinant antibodies, tribodies or bibodies, intrabodies, nanobodies, small modular immunopharmaceuticals (SMIPs), binding domain immunoglobulin fusion proteins, camelized antibodies, and VHH-containing antibodies. Additional examples of antigen-binding antibody fragments are known in the art.
[0122] The term "complementarity determining region" or "CDR" refers to short polypeptide sequences in the variable regions of both heavy and light chain polypeptides that are primarily responsible for mediating specific antigen recognition. The term "framework region" refers to amino acid sequences in the variable regions of both heavy and light chain polypeptides that are not CDR sequences and are primarily responsible for maintaining the proper arrangement of the CDR sequences to allow antigen binding. Although the framework region itself typically does not directly participate in antigen binding, as is known in the art, certain residues in the framework region of a particular antibody may be directly involved in antigen binding or may affect the ability of one or more amino acids in the CDR to interact with the antigen.
[0123] Exemplary antibodies are anti-PCSK-9 mAb (eg, alirocumab), anti-IL-6 mAb (eg, sarilumab), and anti-IL-4 mAb (eg, dupilumab).
[0124] Pharmaceutically acceptable salts of any of the APIs described herein are contemplated for use in the drug or medicament in the drug delivery device. Pharmaceutically acceptable salts include, for example, acid addition salts and base salts.
[0125] Those skilled in the art will appreciate that modifications (additions and / or deletions) to the various components, formulations, devices, methods, systems, and embodiments of the API described herein may be made without departing from the full scope and spirit of the invention, which includes such modifications and all equivalents thereof.
[0126] It will be further apparent to those skilled in the art that various modifications and changes can be made to the present disclosure without departing from the scope of the present disclosure. Furthermore, it should be noted that any reference numbers used in the appended claims should not be construed as limiting the scope of the present disclosure.
[0127] In the following, examples of injection devices having an electronic unit in combination with an external electronic device are explained in more detail with reference to the drawings. [Brief description of the drawings]
[0128] [Figure 1] FIG. 2 shows a schematic longitudinal cross section of an example of an injection device. [Diagram 2] FIG. 2 shows a schematic diagram of the injection device according to FIG. 1, with the distal housing component decoupled from the proximal housing component. [Diagram 3] FIG. 13 shows a longitudinal section through an example of a drive mechanism implemented with an injection device. [Figure 4] FIG. 13 is an exemplary diagram showing the interaction of the electronic unit of the injection device with an external electronic device. [Diagram 5]FIG. 1 is a block diagram of an injection system including an injection device and an external electronic device. [Figure 6] FIG. 13 illustrates a distal housing component comprising an identifier. [Figure 7] FIG. 13 illustrates a distal housing component and medication container with an identifier. [Figure 8] FIG. 2 illustrates an example of an electronic identifier. [Figure 9] FIG. 1 illustrates an example of an optically implemented identifier. [Figure 10] 1 is a flow chart of a method for unlocking the operation of an injection device. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0129] In Fig. 1 to Fig. 3, Fig. 6 and Fig. 7, details of an example of an injection device 10 implemented as a pen-type injector are shown in schematic form. The injection device 10 is part of an injection system or drug delivery system 1, as shown in Fig. 5. The injection device 10 comprises a housing 11. The housing 11 may be of elongated or tubular shape. The housing 11 extends in a longitudinal or axial direction. Towards the distal direction 2, the injection device 10 comprises a protective cap 6 covering a distal housing component 12. The housing 11 further comprises a proximal housing component 14 removably connectable with the distal housing component 12. As becomes clear from Fig. 1, Fig. 2 and Fig. 6, the proximal housing component 14 comprises a connecting end towards the distal direction 2.
[0130] The coupling end of the proximal housing component 14 includes a receptacle 27 configured to receive the complementary proximal coupling end 16 of the distal housing component 12. As shown in Figures 2 and 6, the proximal coupling end 16 of the distal housing component 12 includes an insert portion 17 configured to couple with a distal coupling end 28 of the proximal housing component 14. To that end, the proximal housing component 14 includes a receptacle 27 at the distal coupling end 28 that is configured and shaped to receive the insert portion 17 therein.
[0131] The insert portion 17 has at least one fastening element 19 on its outer surface, implemented for example as a protrusion that mates or engages with a complementary recess on the inner surface of a side wall of the receptacle 27. The insert portion 17 and the receptacle 27 can include corresponding or complementary fastening elements to form a snap-fit engagement, a bayonet joint, or a threaded joint.
[0132] The insert portion 17 is longitudinally limited by a radially outwardly extending flange 18. The flange 18 proximally longitudinally abuts a distal end face of the sidewall or distal end of the proximal housing component 14 when the housing components are fully assembled.
[0133] The distal housing component 12 is implemented as a cartridge holder. It includes a tubular-shaped side wall 13 configured and sized to receive a drug container 30, as shown in FIG. 7. The cartridge holder includes at least one aperture 15 in its tubular-shaped side wall 13, as shown in FIG. 7. The tubular-shaped side wall 13 tapers radially towards the distal end to form a shoulder portion adjacent the distal coupling end 20. The drug container 30 is typically filled with an injectable drug 4, for example provided or stored in liquid form inside the drug container 30.
[0134] The connecting end 20 includes a mount 21 for a needle assembly 23. The needle assembly 23 includes a needle hub 24 configured for removable or releasable engagement with the mount 21, and further includes an injection needle 25. The injection needle 25 is typically implemented as a double-ended injection needle. When properly assembled with the mount 21, the proximal tip of the injection needle 25 passes through the distal through-hole 22 of the connecting end 20 to reach and pierce a seal 35 at the distal end of a drug container 30 located inside the cartridge holder.
[0135] The seal 35 can be implemented as a rubber disk and can act as a pierceable septum. The seal 35 can be mechanically fixed to the distal end of the barrel 31 of the drug container 30 by a crimped metal cap 36. The tubular barrel 31 of the container 30 is sealed towards the proximal end by a stopper 34, implemented for example as a rubber stopper. The piston or stopper 34 is movably arranged inside the barrel 31. The piston or stopper 34 can be displaceable towards the distal direction 2, and thus towards the dosing end of the injection device 10, by the action of a piston rod 40 of a drive mechanism 8 provided and assembled inside the proximal housing component 14.
[0136] The drive mechanism 8 can be implemented in many different ways, in which case the disclosure is in no way limited to the particular example of the drive mechanism 8 currently shown. In the currently shown example, the drive mechanism 8 includes a piston rod 40 with a pressure piece 41 at its distal end. The pressure piece 41 is configured to apply distal pressure to the stopper 34 of the drug container 30. The drive mechanism or injection device further includes a housing insert 42, which serves as a mount for the multiple moving components of the drive mechanism 8.
[0137] Typically, the drive mechanism 8 includes a number sleeve 43 with consecutive sequence numbers on its outwardly facing sidewall. The numbers are visible through a window 26 or a respective aperture in the sidewall 29 of the proximal housing component 14. The drive mechanism 8 further includes a driver 44, which may be implemented as a drive sleeve. For dose setting, the number sleeve 43 typically undergoes rotation relative to the housing 11 along a first rotational direction. During dose dispensing or injection, the number sleeve 43 undergoes rotation along a second, and therefore opposite, rotational direction.
[0138] The driver 44 or drive sleeve can be operatively engaged with the piston rod 40, permanently or non-permanently. At least during dose dispensing, the driver 44 is engaged with the piston rod to transmit force or transmit torque to urge the piston rod 40 in the distal direction 2 for dose ejection or dose injection. In some implementations of the drive mechanism 8, the driver 44 undergoes rotation along a second rotational direction during dose dispensing. In some examples, the driver 44 undergoes rotation along a first rotational direction during and / or for dose setting. In some examples, the driver 44 is non-rotatably and / or axially fixed relative to the housing 11 during dose setting, but is movable during dose dispensing or dose injection.
[0139] The drive mechanism 8 further includes a dose dial 46, for example provided at the proximal end of the proximal housing component 14. The dose dial 46 provides a user-gripable or user-operable tool for dose setting. Typically, the dose dial 46 is rotatable by a user relative to the housing 11 for dose setting. The drive mechanism 8 further includes a trigger 48, for example implemented as a dose button depressible in the distal direction 2 by a user to initiate and / or control the dose dispensing or dose injection process.
[0140] The trigger 48 and the dose dial 46 can be provided on a common member. They can be integrally formed. They can both be located on a so-called dial extension of the injection device 10, which undergoes a helical movement relative to the housing 11 during dose setting and a longitudinal distal movement during and / or for dispensing or injecting a dose. Typically, the trigger 48 is provided at the proximal end of the dose dial 46. The trigger 48 can form or be constructed of a proximal end face of the housing 11.
[0141] In the example of Fig. 3, a number of possible implementations of the interlocks 90, 91, 92, 93, 97, 98, 99 are shown. Here, the interlock 90 is provided as an interlock between the trigger 48 and the dose dial 46. When the interlock 90 is activated, it can effectively block the mutual displacement of the trigger 48 relative to the dose dial 46. When the trigger 48 should be non-rotatably fastened to the housing 11 or the dial extension, the interlock 90 can also be activated to block the rotation of the dose dial 46 relative to the trigger 48 and thus relative to the housing 11. Thus, activation of the interlock 90 can effectively block or halt the dispensing of the dose and / or the dialing or setting of the dose.
[0142] The interlock 91 is mechanically coupled to the proximal housing component 14 and at least one of the dose dial 46, the trigger 48, and the dial extension. Activation of the interlock 91 serves to block or impede at least one of rotational and longitudinal sliding movement of the dose dial 46 relative to the housing component 14. When the interlock 91 is activated, it may effectively block setting of a dose and / or dispensing of a dose.
[0143] The drive mechanism 8 may further include at least a first clutch 45 and a second clutch 47. The clutches 45, 47 allow the drive mechanism 8 to be switched between a dose setting mode and a dose injection mode. Depending on the specific implementation of the drive mechanism 8, the clutches 45, 47 may be operable to engage any two of the following components with each other: the piston rod 40, the housing insert 42, the housing 11, the number sleeve 43, the driver 44, the dose dial 46, and / or the trigger 48. Details of an example of a drive mechanism are further described in document WO2014 / 033195A1. The clutch 45 may comprise a further interlock 93, and the clutch 47 may comprise an interlock 92. The interlock 92 may be operably engaged with the clutch 47. Similarly, the interlock 93 may be operably engaged with the clutch 45.
[0144] When the interlocks 92, 93 are activated, the operation of the respective clutches 47, 48 can be blocked to prevent switching of the drive mechanism 8 from the dose setting mode to the dose injection mode and / or vice versa, i.e. from the dose injection mode to the dose setting mode.
[0145] 3, the number sleeve 43 is selectively engagable with the proximal housing component 14 via an interlock 97. In a further example, the number sleeve 43 is selectively engagable with the housing insert 42 via an interlock 98. In a further example, the number sleeve 43 is selectively engagable with at least one of the dose dial 46 and the trigger 48 via another interlock 99, as shown in FIG.
[0146] Interlock 97 allows for blocking or impeding at least one of rotational and longitudinal movement of number sleeve 43 relative to proximal housing component 14. Interlock 98 allows for selectively blocking or impeding at least one of rotational and longitudinal movement of number sleeve 43 relative to housing insert 42. Because number sleeve 43 undergoes at least one of rotational, helical, or longitudinal sliding movement relative to proximal housing component 14 during dose setting and dose injection, blocking the movement of number sleeve 43, respectively, serves to block or impede at least one of the dose setting and dose injection actions.
[0147] The interlock 99 may block movement, e.g., rotational and / or longitudinal movement, of the dose dial 46 and / or trigger 48 relative to the number sleeve 43. Thus, in a typical implementation of the drive mechanism 8, the interlock 99, when activated, may at least substantially impede or prevent injection of the dose.
[0148] In a typical implementation, each of the interlocks 90, 91, 92, 93, 97, 98, 99 includes an electromechanical actuator and at least one of a latch and a clamp. Thus, the latch or clamp is movable between a locked configuration and an released configuration by the actuator, the operation of which can be controlled, for example, by electrical signals obtained from or generated by the processor 72, the functions of which are described below. Typically, the latch provided on the first component of the injection device 10 is configured for form-fit engagement with the second component of the injection device.
[0149] In other examples where the interlock includes a moveable clamp, the clamp on the first component of the injection device is configured to engage with a second component of the injection device with a friction fit. In any case, activation of the interlock 90, 91, 92, 93, 97, 98, 99 can result in a form-fit and / or frictional engagement between the first and second components of the injection device to block or prevent dose setting and / or dose dispensing.
[0150] The actuators may include electromagnets and / or electromechanical drives controllable by the processor 72. The latches, implemented for example as movable or resiliently deformable bent arms, hooks, or clamps, are movable by the actuators between a locked position in which the interlocks 90, 91, 92, 93, 97, 98, 99 are activated, and a released position in which the interlocks 90, 91, 92, 93, 97, 98, 99 are deactivated. In the deactivated configuration, the interlocks 90 and 91, 92, 93, 97, 98, 99 enable and assist movement of a first component relative to a second component of the drive mechanism to enable at least one of dose setting and dose injection.
[0151] The injection device 10 further comprises an electronic unit 70. In this example, the electronic unit 70 is embedded inside the drug delivery device 10. The electronic unit 70 is located at or near the proximal end of the housing 11. It may be located inside or disposed in a dial extension of the injection device 10. In the example shown in Figs. 3 and 4, the electronic unit 70 is located inside a hollow space of the cylindrical dose dial 46, which space is covered and / or closed in the proximal direction 3 by the trigger 48. Here, the trigger 48 provides an end cap forming a proximal closure of the hollow dose dial 46. In some examples, the trigger 48 and the dose dial 46 are integrally formed.
[0152] The electronic unit 70 includes a printed circuit board 71 that comprises a processor 72. The electronic unit 70 further comprises a source of electrical energy, typically implemented as an electric battery 73. As illustrated, the processor 72 and the battery 73 may be provided on opposite sides of the printed circuit board 71.
[0153] The electronic unit 70 is shown diagrammatically in the block diagram of FIG. 5. The electronic unit 70 further includes at least one short-range communication interface 76 operable to communicate with a corresponding short-range communication interface 86 of the external electronic device 80. The processor 72 is connected to an interlock 90 and operable to control the operation of the interlock 90. The interlock 90 may be implemented as an electromechanical interlock. The interlock 90 may include a latch or any other type of mechanically movable component to block or prevent operation of the drive mechanism 8.
[0154] Typically, the latch or movable component of the interlock 90 is movable through and by an actuator electronically controllable by the processor 72. The electronic unit 70 is operable to communicate with an external electronic device 80 by means of a short-range communication interface 76. Optionally, the electronic unit 70 comprises a sensor 74 operable to detect or measure the movement of at least one movable component 7 of the drive mechanism 8. The movable component 7 can be represented by any of the movable components mentioned above, for example the piston rod 40, the number sleeve 43, the driver 44, the trigger 48, the dose dial 46, and / or the clutches 45, 47. The sensor 74 can be implemented as one of an optical, capacitive, inductive, optical, or acoustic sensor, and allows the operation of the drive mechanism 8, and thus the injection device 10, to be managed and monitored.
[0155] Information regarding the size of the dose currently being set, dialed or dispensed may be obtained by the sensor 74 and stored in local storage 75. Data captured or acquired during repeated and subsequent uses of the injection device 10 may be stored in storage 75. Such injection-related data stored in storage 75 may be synchronized by short-range communications interface 76 with an external electronic device 80 and / or an external database 96, for example hosted or provided by a healthcare provider.
[0156] The external electronic device 80 includes a wireless reader interface 85 configured to read or capture the identifier 50 provided on or associated with the medication container 30. The information content or data of the identifier 50 can be detected or read by the external electronic device 80, and in particular by the wireless reader interface 85. The information collected by the wireless reader interface 85 can be transmitted to the electronic unit 70 of the injection device via a communication link between the short-range communication interface 76 of the electronic unit 70 and a corresponding short-range communication interface 86 of the external electronic device 80.
[0157] Typically, the external electronic device 80 is implemented as a smartphone, a smartwatch, or a tablet computer. The external electronic device 80 may include a long-range communication interface 88 that establishes a communication link to an external database 96 by way of a communication network 94. Typically, the external electronic device 80 is a mobile device or a wearable device. It includes a display 81 and / or a speaker 82 for communicating with a user.
[0158] The wireless reader interface 85 may include a near field communication interface 84 and / or a camera 83. The camera 83 may be operable to read the identifier 50 when implemented as an optical identifier 54 as shown in Figure 9. The optical identifier 54 may include a one- or two-dimensional optical code 58, such as a QR code or a data matrix code, that is captureable by the camera 83 of the external electronic device 80.
[0159] In another example, as shown in Figure 8, the identifier 50 is implemented as a passive electronic identifier 52. Here, the identifier 50 may include a near field communication tag 53 with an antenna 55 and a microchip 56. The microchip 56 may include local storage or memory 57, for example, for storing medication-related information and / or for storing medication container-related information. The memory 57 may be implemented as a read-only memory or a re-writable memory.
[0160] In either case, the identifier 50 may include a flat substrate 51 for attaching the identifier 52 to the sidewall 13 of the distal housing component 12 or to the sidewall of the barrel 31 of the medication container 30. The flat substrate 51 may include a flexible or deformable sheet structure having an adhesive layer that adhesively attaches the substrate 51, and thus the identifier 50, to the housing component 12 or medication container 30.
[0161] The identifier 50, implemented as an optical identifier 54 or a passive electronic identifier 52, may be permanently disposed on or in the medication container 30 and / or on or in the distal housing component 12. The information or data stored or provided by the identifier 50 may indicate a medication type or name, a medication manufacturing date, a medication expiration date, a medication lot number, and / or a unique medication container ID. The data or information provided by the identifier 50 may be acquired, extracted, captured, or obtained via a wireless reader interface 85 of the external electronic device 80.
[0162] The respective information can be processed or pre-processed by the external electronic device 80, or can simply be sent or transmitted to the electronic unit 70 by the communication link between the short-range communication interface 76 and the corresponding short-range communication interface 86. Thus, the respective processing of the data obtained and extracted from the identifier 50 can also be performed by the processor 72 of the electronic unit 70. Here, the external electronic device 80 can simply provide or act as a relay. In this way, the electronic unit 70 can be provided with data or information provided or stored by the identifier 50, but the electronic unit 70 itself cannot operate to read or capture the data or information provided by the identifier 50.
[0163] Such an approach is particularly beneficial to avoid the implementation of a short-range communication interface for the electronic unit 70. It is sufficient for the electronic unit 70 to have only one communication interface, namely the short-range communication interface 76, for example for exchanging data or information with the external electronic device 80. The external electronic device 80 can easily have two different wireless communication interfaces, namely the short-range communication interface 86, implemented for example as a Bluetooth or Wi-Fi interface, communicating with the short-range communication interface 76 of the electronic unit 70. The external electronic device 80 can easily have a further communication interface, implemented as a short-range communication interface 84, for reading or capturing data or information provided by the identifier 50.
[0164] When implemented as a passive electronic identifier 52, for example as an NFC tag 53, it may be necessary to bring the external electronic device 80 close to the identifier 50, which may be located inside the housing 11 of the injection device 10. Typically, the transmission range of the near-field communication interface 84 is only a few centimetres. Upon establishing a communication link, for example upon reading the passive electronic identifier 52 by the near-field communication interface 84, the external electronic device 80 may provide an audible or visual confirmation to the user. A display 81 and / or a speaker 82 may inform the user that the electronic identifier 52 has been successfully read.
[0165] The external electronic device 80 can be wirelessly paired to the electronic unit 70. Upon successful transfer of the data or information of the identifier 50 to the electronic unit 70 via the communication link between the short-range communication interfaces 86, 76, another visual and / or audio confirmation can be provided to the user, for example, by the electronic unit 70 and / or the external electronic device 80.
[0166] If recognition or processing of the identifier 50 data or information obtained via the short-range communications interface 76 determines that the medication container 30 is intended for use with the injection device 11, the processor 72 is operable to deactivate the interlock 90, thereby allowing a dose of medication to be set and / or dispensed or injected.
[0167] The processor 72 and / or the at least one interlock 90, 91, 92, 93 can be implemented in a variety of different ways. In one approach, the interlock 90 or locking mechanism may be operable to lock the setting of a dose, lock the dispensing of a dose, and / or lock both the setting and dispensing of a dose.
[0168] The interlock 90 and / or the processor 72 can further be configured to implement, for example, an automatic relock after the respective dosing or injection procedure is finished. Furthermore, based on a signal obtainable from the sensor 74, the processor 72 can be provided with information indicative of the remaining fill level of the medicament container 30. Thus, the processor 72 can invoke activation of the interlock 92 upon providing the sensor 74 with a respective sensor signal that the medicament container 30 is substantially depleted or empty. Removal or insertion of the medicament container 30, as well as decoupling or recoupling of the housing components 12, 14, can trigger the deactivation of the automatic locking or drive mechanism for dose setting and / or dosing.
[0169] The information provided by the identifier 50 and captureable by the wireless reader interface 85 may also include tamper protection, whereby a unique code must be verified by the electronic unit 70 and / or by data exchange or validation with an external database 96.
[0170] In a typical usage scenario shown in Fig. 10, in a first step 100, a user can bring an external electronic device 80 into close proximity with the injection device 10. In a subsequent step 102, the wireless reader interface 85 captures or reads an identifier 50 provided on one of the distal housing component 12 and the medication container 30. In a further step 104, the respective information captured by the wireless reader interface 85 is transmitted via the short-range communication interfaces 76, 86 to the electronic unit 70 of the injection device 10.
[0171] In a subsequent step 106, the processor 72 performs a data check and evaluates or processes the data obtained from the short-range communication interface 76. If the medicament container 30 is intended for use with a particular injection device 10, the respective data is approved and in step 108 the interlock 90 is controlled or operated by the processor 72 to unlock the drive mechanism 8 of the injection device 10. The user can then start using the injection device 10 for setting a dose of medicament 4 and / or injecting the dose. In other situations, when the medicament container 30 is not intended for use with the injection device 10, the interlock 90 is triggered to block or lock the drive mechanism 8 of the injection device 10. [Explanation of symbols]
[0172] 1. Drug Delivery Systems 2 Distal direction 3 Proximal direction 4. Drugs 6 Protective cap 7 Movable components 8 Driving mechanism 10 Injection Device 11. Housing 12 Housing Components 13 Side wall 14 Housing Components 15 Aperture 16 Connecting end 17 Insertion 18 Flange 19 Fastening Elements 20 Connecting end 21 Mount 22 Through hole 23 Needle Assembly 24 Needle Hub 25 Syringe needle 26 Windows 27 Receptacle 28 Connecting end 30 containers 31 barrels 32 Side wall 34 Stopper 35 Sealing part 36 Cap 40 Piston rod 41 Pressure Components 42 Housing insert 43 Number Sleeve 44 Drivers 45 Clutch 46 Dose Dial 47 Clutch 48 Trigger 50 Identifier 51 Substrate 52 Electronic Identifiers 53 NFC Tags 54 Optical Identifiers 55 Antenna 56 Chips 57 Memory 58 Code 70 Electronic Unit 71 Printed Circuit Board 72 processors 73 Battery 74 Sensors 75 Storage 76 Short Range Communication Interface 80 External Electronic Devices 81 Display 82 Speaker 83 Camera 84 Short-range communication interface 85 Wireless Reader Interface 86 Short Range Communication Interface 88 Telecommunications Interface 90 Interlock 91 Interlock 92 Interlock 93 Interlock 94 Network 96 Databases
Claims
1. An injection device (10) for injecting a dose of a medicament (4), comprising: a housing (11) configured to receive a drug container (30); a drive mechanism (8) operably engageable with the medicament container (30) for expelling or drawing a dose of the medicament (4) from the medicament container (30), the drive mechanism (8) including at least one interlock (90, 91, 92, 93) configured to override at least one of dose setting and dose dispensing; an identifier (50) on or associated with the medication container (30); an electronic unit (70) operable to control at least one interlock (90, 91, 92, 93) and including a short-range communication interface (76) for communicating with a corresponding short-range communication interface (86) of an external electronic device (80) to obtain information indicative of the identifier (50), the electronic unit (70) being configured to process a signal of the short-range communication interface (76) to at least temporarily deactivate the at least one interlock (90, 91, 92, 93); The injection device comprising:
2. 2. The injection device (10) of claim 1, wherein the housing (11) comprises a distal housing component (12) and a proximal housing component (14), the distal housing component (12) configured to accommodate the drug container (30) and the proximal housing component (14) configured to accommodate or support the drive mechanism (8).
3. 3. The injection device (10) of claim 2, wherein the identifier (50) is located on or inside the distal housing component (12) and the electronic unit (70) is provided in or on the proximal housing component (14).
4. An injection device (10) according to any one of claims 1 to 3, wherein the identifier (50) comprises at least one of an optical code (58) and a visual code captureable by an external electronic device (80).
5. An injection device (10) according to any one of the preceding claims, wherein the identifier (50) comprises a passive electronic identifier (52).
6. 6. The injection device (10) of claim 5, wherein the passive electronic identifier (52) comprises a near field communication (NFC) tag (53) configured to communicate with a corresponding near field communication interface (84) of an external electronic device (80).
7. An injection device (10) according to claim 6, wherein the electronic unit (70) of the injection device does not have a corresponding near field communication interface or NFC reader.
8. The injection device (10) according to any one of the preceding claims, wherein the short-range communication interface (76) comprises a wireless communication interface (76) based on one of the following communication standards: Bluetooth, Bluetooth low energy (BLE), Zigbee or Wi-Fi.
9. At least one interlock (90, 91, 92, 93) includes an electromechanical interlock configured to mechanically engage a first component (40, 42, 44) of the injection device (10) and a second component (43, 46, 48) of the injection device (10), the first component (40, 42, 44) being movable relative to the second component (43, 45, 46, 47, 48) for at least one of dose setting and dose injection.
9. An injection device (10) according to any one of claims 1 to 8, wherein at least one interlock (90, 91, 92, 93) is operable to switch between an interlocked state in which the first component (40, 42, 44) is movably locked to the second component (43, 45, 46, 47, 48) and a released state in which the first component (40, 42, 44) is movable relative to the second component (43, 45, 46, 47, 48).
10. 10. The injection device (10) of any one of claims 1 to 9, wherein the drive mechanism (8) includes at least one clutch (45, 47) operable to switch the drive mechanism between a dose setting mode and a dose injection mode, and wherein the at least one interlock (92, 93) is operably engaged with the at least one clutch (45, 47) to selectively disable switching of the drive mechanism (8) from one of the dose setting mode and the dose injection mode to the other of the dose setting mode and the dose injection mode.
11. An injection device (10) according to any one of the preceding claims, wherein the electronic unit (70) is not operable to collect or read information of the identifier (50).
12. An electronic device (80) comprising: A short-range communication interface (86) operable to communicate with the short-range communication interface (76) of the injection device (10) according to any one of claims 1 to 11; a wireless reader interface (85) coupled to the short-range communications interface (86) and operable to capture or read an identifier (50) provided on or associated with a medication container (30) of the injection device (10); The electronic device comprising:
13. The wireless reader interface (85) includes: a camera (83) for capturing the optical code (58) of the identifier (50); and A short-range communications interface (84) for communicating with the passive electronic identifier (52) of the identifier (50). The electronic device (80) of claim 12, comprising at least one of:
14. 14. The electronic device (80) of claim 12 or 13, further comprising a long range communications interface (88) configured to communicate with a database (96) over a network (94).
15. An injection system comprising an injection device (10) according to any one of claims 1 to 11 and comprising an electronic device (80) according to any one of claims 12 to 14.
16. A method for unlocking the operation of an injection device (10) for at least one of setting and injecting a dose of a medication (4), the injection device (10) comprising: a housing (11) configured to receive a drug container (30); a drive mechanism (8) operably engageable with the medicament container (30) for expelling or drawing a dose of the medicament (4) from the medicament container (30); The drive mechanism (8) includes at least one interlock (90, 91, 92, 93) configured to override at least one of dose setting and dose dispensing, and the method comprises: capturing or reading an identifier (50) provided on or associated with the medication container (30) using a wireless reader interface (85) of the external electronic device (80); Establishing a communication link between a short-range communication interface (76) of the injection device (10) and a corresponding short-range communication interface (86) of the electronic device (80); transmitting information indicative of the identifier (50) from the electronic device (80) to the injection device (10) in order to at least one of temporarily deactivate and reactivate at least one interlock (90, 91, 92, 93); The method comprising:
17. A computer readable medium comprising instructions which, when executed by an electronic device (80) according to any one of claims 12 to 14, capturing or reading an identifier (50) on or associated with the medication container (30); Establishing a communication link between a short-range communication interface (76) of an injection device according to any one of claims 1 to 9 and a corresponding short-range communication interface (86) of an electronic device (80); transmitting information indicative of the identifier (50) from the electronic device (80) to the injection device (10) in order to at least temporarily deactivate at least one interlock (90, 91, 92, 93); The computer-readable medium causes an electronic device (80) to execute the method.
Citation Information
Patent Citations
drug delivery device
JP2018506401A
Augmented reality for drug delivery devices
US20210280291A1
Drug delivery device and drug delivery system
WO2020127139A1
